These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 8914202)

  • 21. The changing controversy over surgical resection margins for stage I cutaneous melanoma.
    Green MS
    Mt Sinai J Med; 1991 Sep; 58(4):341-6. PubMed ID: 1944321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of malignant melanoma.
    Kroon BB; Nieweg OE
    Ann Chir Gynaecol; 2000; 89(3):242-50. PubMed ID: 11079795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical management of melanoma-in-situ using a staged marginal and central excision technique.
    Möller MG; Pappas-Politis E; Zager JS; Santiago LA; Yu D; Prakash A; Kinal A; Clark GS; Zhu W; Puleo CA; Glass LF; Messina JL; Sondak VK; Cruse CW
    Ann Surg Oncol; 2009 Jun; 16(6):1526-36. PubMed ID: 19050971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanoma in children and the use of sentinel lymph node biopsy.
    Bütter A; Hui T; Chapdelaine J; Beaunoyer M; Flageole H; Bouchard S
    J Pediatr Surg; 2005 May; 40(5):797-800. PubMed ID: 15937817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excision margins for primary cutaneous melanoma: updated pooled analysis of randomized controlled trials.
    Lens MB; Nathan P; Bataille V
    Arch Surg; 2007 Sep; 142(9):885-91; discussion 891-3. PubMed ID: 17875844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
    Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
    Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective population-based study of cutaneous malignant melanoma of the head and neck.
    Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
    Laryngoscope; 2000 Sep; 110(9):1498-504. PubMed ID: 10983950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: recurrence and survival study.
    Gomez-Rivera F; Santillan A; McMurphey AB; Paraskevopoulos G; Roberts DB; Prieto VG; Myers JN
    Head Neck; 2008 Oct; 30(10):1284-94. PubMed ID: 18704971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is incisional biopsy of melanoma harmful?
    Martin RC; Scoggins CR; Ross MI; Reintgen DS; Noyes RD; Edwards MJ; McMasters KM
    Am J Surg; 2005 Dec; 190(6):913-7. PubMed ID: 16307945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staging work-up and post-treatment surveillance of patients with melanoma.
    Olson JA; Jaques DP; Coit DG; Hwu WJ
    Clin Plast Surg; 2000 Jul; 27(3):377-90, viii. PubMed ID: 10941559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Occult tumor cells of malignant melanoma and consequences for surgical treatment].
    Kühnel G; Schönfelder M
    Zentralbl Chir; 1998; 123(7):834-9. PubMed ID: 9746984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolution of the management of regional lymph nodes in melanoma.
    Landry CS; McMasters KM; Scoggins CR
    J Surg Oncol; 2007 Sep; 96(4):316-21. PubMed ID: 17879333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Head and neck cutaneous melanoma: a retrospective observational study on 146 patients.
    Koskivuo IO; Kinnunen IA; Suominen EA; Talve LA; Vihinen PP; Grénman RA
    Acta Oncol; 2009; 48(3):460-7. PubMed ID: 18843562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Surgical treatment of malignant melanoma in the head and neck (author's transl)].
    Nagel F
    Laryngol Rhinol Otol (Stuttg); 1974 Apr; 53(4):241-8. PubMed ID: 4599369
    [No Abstract]   [Full Text] [Related]  

  • 37. Incisional biopsy and melanoma prognosis: Facts and controversies.
    Pflugfelder A; Weide B; Eigentler TK; Forschner A; Leiter U; Held L; Meier F; Garbe C
    Clin Dermatol; 2010; 28(3):316-8. PubMed ID: 20541685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excision guidelines and follow-up strategies in cutaneous melanoma: Facts and controversies.
    Leiter U; Eigentler TK; Forschner A; Pflugfelder A; Weide B; Held L; Meier F; Garbe C
    Clin Dermatol; 2010; 28(3):311-5. PubMed ID: 20541684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical management of primary and recurrent melanoma.
    Farma JM; Kulkarni N; Hsu C
    Surg Oncol Clin N Am; 2015 Apr; 24(2):239-47. PubMed ID: 25769709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent cutaneous melanoma: a surgical perspective.
    Yeung RS
    Semin Oncol; 1993 Oct; 20(5):400-18. PubMed ID: 8211191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.